• Dec 25, 2024

Better Buy in 2025: XRP or Bitcoin?

The total value of all coins and tokens across the industry currently stands at $3.5 trillion, more than doubling from where it ended in 2023. Industry-leading cryptocurrencies like Bitcoin (CRYPTO: BTC) are responsible for most of that added value, but many tokens at the more speculative end of the market have also delivered solid gains. XRP could be one of the biggest beneficiaries of that regulatory shift, but will it be a better buy than Bitcoin in 2025?

  • Dec 24, 2024

Should You Forget Bitcoin and Buy Solana Instead?

Bitcoin's (CRYPTO: BTC) price hit an all-time high of $103,332 on Dec. 4. Bitcoin's price has pulled back to about $97,000 as of this writing, but it remains up more than 120% over the past 12 months. Bitcoin is still a solid long-term play on the cryptocurrency market, but it might have less upside potential than its smaller coins.

  • Dec 24, 2024

Ex-Comedian Joins Ex-Goldman Analyst to Advise Japan Stock Fund

(Bloomberg) -- A former comedian and an ex-Goldman Sachs Group Inc. analyst will offer investment advice for a Japanese equity fund that’s set to launch in January.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayThe fund will be run by Tokyo-based asset management firm Fundnote, and will invest in stocks with limited downside by looking at their price-earnings ratio and price-to-cash flow ratio, among other measures, and it seek to capture so-called alpha, acc

  • Dec 24, 2024

Optical Cable Reports Strong Q4 Amid Market Challenges

Optical Cable ( (OCC) ) has released its Q4 earnings. Here is a breakdown of the information Optical Cable presented to its investors. Optical Cable Corporation is a prominent manufacturer of fiber optic and copper data communication cabling and connectivity solutions, serving various markets including enterprise and wireless carriers, known for its innovative technology and robust product offerings. In its latest earnings report, Optical Cable Corporation announced a notable increase in net sal

  • Dec 24, 2024

Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position

Psyence Biomedical ( (PBM) ) has provided an announcement. Psyence Biomedical Ltd. has regained compliance with all Nasdaq continued listing requirements after transferring from The Nasdaq Global Market to The Nasdaq Capital Market. This was achieved through a 75-for-1 share consolidation, meeting the $1 minimum bid price requirement. With a debt-free balance sheet and $5.6 million in cash, the company is now well-positioned to advance its business plans and clinical trials, having begun patient

  • Dec 24, 2024

Investcorp Europe Navigates Management Shift and Nasdaq Delisting

Investcorp Europe Acquisition Corp. I Class A ( (IVCB) ) has provided an update. Investcorp Europe Acquisition Corp. I has completed a significant management transition as part of a Sponsor Handover, involving the sale of shares and warrants to Samara Special Opportunities, along with a reshuffle of its board of directors. This transition coincides with a delisting notice from Nasdaq due to the company’s failure to complete an initial business combination within the required timeframe. Despite t